-
Founded in:
1990-09-14 -
Country:
China -
Address:
Wuhan Pharmaceutical Industrial Park, Miaoshan Community, East Lake New Technology Development Zone, Wuhan, Hubei Province -
Tax NO.:
91420115177689464G -
Registered Funds:
30 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lipoic acid |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
62-46-4 | 18 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pancreatin |
Contains pancreatic lipase, pancreatic amylase, and trypsin, which can break down fat into glycerol and fatty acids, convert starch into sugar, and convert protein into peptone
More
Contains pancreatic lipase, pancreatic amylase, and trypsin, which can break down fat into glycerol and fatty acids, convert starch into sugar, and convert protein into peptone |
300mg | 8049-47-6 | 27 |
| Pepsin |
Can convert protein into albumen and peptone
More
Can convert protein into albumen and peptone |
13mg | 9001-75-6 | 21 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Heparin sodium |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
9041-08-1 | 82 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nateglinide |
Nateglinide is an amino acid derivative and an oral antidiabetic drug used to treat patients with type 2 diabetes. The action of nateglinide depends on the function of pancreatic beta cells. Nateglinide binds to the ATP-sensitive K channel receptor on the beta cell membrane and closes it, causing cell depolarization, calcium channel opening, calcium influx, stimulating insulin secretion, and lowering blood sugar. The insulin secretion-promoting effect of nateglinide depends on the glucose level. When the glucose level is low, the insulin secretion is weakened. Nateglinide has a high degree of tissue selectivity and has a low affinity for cardiac muscle and skeletal muscle.
More
Nateglinide is an amino acid derivative and an oral antidiabetic drug used to treat patients with type 2 diabetes. The action of nateglinide depends on the function of pancreatic beta cells. Nateglinide binds to the ATP-sensitive K channel receptor on the beta cell membrane and closes it, causing cell depolarization, calcium channel opening, calcium influx, stimulating insulin secretion, and lowering blood sugar. The insulin secretion-promoting effect of nateglinide depends on the glucose level. When the glucose level is low, the insulin secretion is weakened. Nateglinide has a high degree of tissue selectivity and has a low affinity for cardiac muscle and skeletal muscle. |
105816-04-4 | 24 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| LIVER EXTRACT |
|
0 |